In addition, high A3B expression in breast cancer is associated with aggressive clinicopathological characteristics [15,16,17,18] resulting in increased metastatic potential, as well as worse prognosis in treatment-naïve disease [13,16,17]. The gene discussed is APOBEC3B; the disease is breast cancer.